Muscle relaxants are a diverse group of medicines that have the ability to relax or reduce tension in muscles. These are used to treat conditions such as muscle pain, spasm, and hyperreflexia. The two types of muscle relaxants available in the market are centrally acting muscle relaxants and direct acting muscle relaxants. Direct acting muscle relaxants are also known as neuromuscular blocking agents. These have no central nervous system activity and act by interfering with transmission of neurons at the neuromuscular junction end plate. Direct acting muscle relaxants are generally used as anesthetics during surgery and long term basis to allow controlled mechanical ventilation in patients in intensive care units. Centrally acting muscle relaxants are also known as spasmolytic agents. These act by blocking excessively stimulated neuronal pathway in the brain and spinal cord. Spasmolytic agents are useful in controlling musculoskeletal pain and spasm. Only three muscle relaxants — baclofen, dantrolene, and tizanidine — have been approved by the FDA to treat spasticity. However, six muscle relaxants — carisoprodol, chlorzoxazone cyclobenzaprine, methocarbamol, metaxalone, and orphenadrine — have been approved to treat muscle spasm. Muscle relaxants are powerful drugs; however, these can have adverse side effects such as heart failure, sedation, and paralysis. Most patients report sedation as a common adverse effect. Hence, doctors generally advise against driving or operating heavy machinery after muscle relaxant administration.

Rise in number of surgeries and increase in geriatric population are projected to drive the global muscle relaxant drugs market during the forecast period. Additionally, rise in prevalence of chronic lower back pain is anticipated to propel the global market in the near future. According to the WHO, lifetime prevalence of non-specific lower back pain is estimated at 60% to 70% in industrialized countries. However, side effects and abuse potential of drugs are likely to restrain the global muscle relaxant drugs market.

The global muscle relaxant drugs market can be segmented based on drug class, route of administration, distribution channel, and region. In terms of drug class, the global market can be categorized into peripherally acting muscle relaxants and centrally acting muscle relaxants. Based on route of administration, the global muscle relaxant drugs market can be bifurcated into oral and injectable. In terms of distribution channel, the global market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies.

Geographically, the global muscle relaxant drugs market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to account for the largest share of the global market because of significant number of surgical procedures performed in the U.S., increase in prevalence of chronic lower back pain, and high per capita income. According to National Center for Complementary and Integrative Health (NCCIH) report 2016, over 50% (125 million) adults in the U.S. had a musculoskeletal pain disorder in 2012. Europe is expected to be the second largest market for muscle relaxant drugs during the forecast period due to advancement in surgical procedures and rise in usage of muscle relaxants in pain management. The muscle relaxant drugs market in Asia Pacific is likely to expand rapidly during the forecast period. Growth of the market in the region can be attributed to rise in number of cosmetic surgeries, surge in income, increase in number of hospitals, and better access to health care. Additionally, expansion activities by key players in the region and launch of generic muscle relaxant drug formulations propel the growth of the muscle relaxant drugs market in the region.

Key players operating in the global muscle relaxant drugs market are AbbVie, Inc., Sandoz, Inc. (Novartis AG), Abbott Laboratories, Pfizer, Inc., Merck & Co., Inc., MedPointe Pharmaceuticals, Meda Pharmaceuticals, Inc., Valeant Pharmaceutical International, Inc., Ipsen Biopharmaceuticals, Inc., and Acorda Therapeutics, Inc., among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Muscle Relaxant Drugs Market